Funding for Retinitis Pigmentosa and AMD Research at Harvard Medical School

Schepens Eye Institute at Harvard Medical School received an unrestricted grant to develop human retinal cell based therapies for eye diseases.  Although the initial focus is on retinitis pigmentosa, the program will have applications for age-related macular degeneration as well.

SEE FULL STORY

Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.